Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
Susana S. Najera(Frederick National Laboratory for Cancer Research), Jordan L. Meier(National Cancer Institute)
Cited by 8
Related Papers
Cytidine acetylation yields a hypoinflammatory synthetic messenger RNA
|Cell chemical biology|2021|35
A chemoproteomic portrait of the oncometabolite fumarate
|bioRxiv (Cold Spring Harbor Laboratory)|2018|9
Conditional Covalent Lethality Driven by Oncometabolite Accumulation
|ACS Chemical Biology|2022|7
Hierarchical small molecule inhibition of MYST acetyltransferases
|Nature Communications|2025|1
A sequence-specific RNA acetylation catalyst
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0